Best Researcher Award
Naresh Konduru
MASUU Global Solutions Pvt Ltd, India
Naresh Konduru is a chemistry researcher whose publication record focuses on analytical methods, pharmaceutical quality assessment, impurity determination, stability studies, and analytical quality by design. The available research profile records 25 documents, 385 citations, and an h-index of 12. Recent publications demonstrate continued engagement with analytical challenges associated with pharmaceutical substances and drug products.
Abstract
Naresh Konduru’s research profile is centered on analytical chemistry applied to pharmaceutical development and quality control. His recent work addresses inorganic impurity quantification, process- and degradation-related impurities, antimicrobial-agent estimation, stability-indicating chromatography, and robustness assessment using analytical quality by design principles. These studies illustrate the application of instrumental and chromatographic techniques to improve analytical reliability and pharmaceutical quality evaluation. [1][2]
Keywords
Analytical chemistry; pharmaceutical analysis; liquid chromatography; ICP-MS; impurity profiling; stability-indicating methods; analytical quality by design; method validation; drug substances; drug products.
Introduction
Pharmaceutical analytical chemistry supports the identification, measurement, and control of substances that can influence drug quality, safety, and performance. Recent publications associated with Konduru examine analytical problems across anticancer medicines, tuberculosis treatment products, semisolid formulations, and diabetes-related pharmaceuticals. The work reflects a methodological emphasis on sensitive measurement, stability evaluation, validation, and robustness.
Research Profile
The profile identifies Chemistry as the principal subject area. The reported Scopus record contains 25 documents and 385 citations, with an h-index of 12. These bibliometric indicators provide a quantitative description of the indexed research record and should be interpreted alongside publication quality, methodological contribution, and relevance to the field.
Research Contributions
- Quantitative determination of inorganic impurities using ICP-MS in pharmaceutical drug substances. [1]
- Development of robust LC methods for process- and degradation-related impurities. [2]
- Application of stability-indicating chromatographic methods and analytical quality by design principles. [4]
Publications
- Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS — Journal of AOAC International, 2026.[1]
- Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product — Biomedical Chromatography, 2026. [2]
- Estimation of Antimicrobial Agent (Sorbic Acid) in Semisolid Dosage Form — Biomedical Chromatography, 2026. [3]
- Development and Validation of a Stability-Indicating LC Method for the Determination of Empagliflozin-Related Substances — Separation Science Plus, 2026. [4]
- Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Darolutamide and Its Degradation Impurities — Separation Science Plus, 2025. [5]
Research Impact
The reported citation count of 385 and h-index of 12 indicate measurable scholarly visibility within the indexed research record. More specifically, the recent publications address practical analytical requirements in pharmaceutical research, including impurity control, formulation stability, method robustness, and quantitative analysis. [1][5]
Award Suitability
The available record provides a substantive basis for consideration for the Best Researcher Award within Chemistry. Relevant factors include a documented publication portfolio, indexed scholarly output, citation activity, and recent research addressing contemporary pharmaceutical analytical challenges. Award assessment should additionally consider originality, methodological rigor, independent contribution, and broader research significance.
Conclusion
Naresh Konduru’s research profile demonstrates sustained activity in analytical chemistry, particularly in pharmaceutical impurity analysis, chromatographic method development, stability assessment, and quality by design. The combination of publication activity and reported citation indicators supports consideration within the International Academic Excellence Awards framework.
External Links
References
- Elsevier. (n.d.). Scopus author details: Naresh Konduru, Author ID 57200528602. Scopus.
Scopus Author Profile
- Konduru, N. et al. (2026). Quality by Design-Based Development of a Robust LC Method for Simultaneous Estimation of Process- and Degradation-Related Impurities in Rifapentine Drug Product. Biomedical Chromatography.
https://doi.org/10.1002/bmc.70430
- Konduru, N. et al. (2026). Estimation of Antimicrobial Agent (Sorbic Acid) in Semisolid Dosage Form. Biomedical Chromatography.
https://doi.org/10.1002/bmc.70412
- Konduru, N. et al. (2026). Development and Validation of a Stability-Indicating LC Method for the Determination of Empagliflozin-Related Substances. Separation Science Plus.
https://doi.org/10.1002/sscp.70182
- Konduru, N. et al. (2025). Development and Validation of a Stability-Indicating Liquid Chromatographic Method for Darolutamide and Its Degradation Impurities. Separation Science Plus.
https://doi.org/10.1002/sscp.70158